Prime Medicine, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Cambridge, MA
PRME chart
What traders are saying about $PRME
Latest postsPrime Medicine, Inc. news
- Prime Medicine (NASDAQ:PRME) Shares Down 6.7% - Time to Sell?
MarketBeat ·
- Prime Medicine to Present at Jefferies Global Healthcare Conference
Yahoo Finance ·
- A gene-editing company’s CEO will speak in London on Nov. 16.
Stock Titan ·
- Sumitomo Mitsui Trust Group Inc. Buys 498,612 Shares of Prime Medicine, Inc. $PRME
MarketBeat ·
- First Trust Heitman Glbl Prm Rl Estt ETF (PRME) stock price, news, quote and history
Yahoo Finance UK ·
- Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates
Yahoo Finance ·
- Jones Trading initiates Prime Medicine stock coverage with buy rating
Investing.com ·
- Prime Medicine, Inc. (PRME) Surges 23.2%: Is This an Indication of Further Gains?
Yahoo Finance ·
- PRME, BEAM, EDIT, NTLA, CRSP Stocks Gain As FDA Signals Faster Route For Patient-Specific Gene Edits
stocktwits.com ·
- Prime Medicine Stock Rallies Nearly 26% in a Month: Here's Why
Yahoo Finance ·
- Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
Yahoo Finance ·
- Temporary Weakness in Intellia Stock Seems Like a Buying Opportunity
barchart.com ·
Prime Medicine, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $4.6M | $3.0M | $0 | $0 |
| Net income | -$201.1M | -$195.9M | -$198.1M | -$121.8M |
| Diluted EPS | $-1.35 | $-1.65 | $-2.18 | $-4.19 |
| Total assets (year end) | $342.7M | $297.5M | $193.9M | $360.3M |
| Cash and equivalents (year end) | $63.0M | $182.5M | $41.6M | $187.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Prime Medicine, Inc.
- Ticker
- PRME (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1894562
Frequently asked questions
What exchange is Prime Medicine, Inc. listed on?
Prime Medicine, Inc. trades on the Nasdaq under the ticker symbol PRME.
What industry is Prime Medicine, Inc. in?
Prime Medicine, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Prime Medicine, Inc. headquartered?
Prime Medicine, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Prime Medicine, Inc.'s fiscal year end?
Prime Medicine, Inc.'s fiscal year ends on December 31.
How much revenue did Prime Medicine, Inc. report?
Prime Medicine, Inc. reported $4.6M in revenue for calendar year 2025, according to its SEC filings.